The roles of interleukin-17 (IL-17) and neutrophils in the lung have been described as those of two intricate but independent players. Here we identify neutrophils as the primary IL-17-secreting subset of cells in a model of inhalation anthrax using A/J and C57BL/6 mice. With IL-17 receptor A knockout (IL-17RA ؊/؊ ) mice, we confirmed that IL-17A/F signaling is instrumental in the self-recruitment of this population. We also show that the IL-17A/F axis is critical for surviving pulmonary infection, as IL-17RA ؊/؊ mice become susceptible to intranasal infection by Bacillus anthracis Sterne spores. Strikingly, infection with a fully virulent strain did not affect IL-17RA ؊/؊ mouse survival. Eventually, by depleting neutrophils in wild-type and IL-17RA ؊/؊ mice, we demonstrated the crucial role of IL-17-secreting neutrophils in mouse survival of infection by fully virulent B. anthracis. This work demonstrates the important roles of both IL-17 signaling and neutrophils in clearing this pathogen and surviving pulmonary B. anthracis infection.
T
he lung is a delicate and vital organ which is constantly exposed to pollutants and pathogens through air sampling (22) . To achieve gaseous exchange through the thin membranes separating air in the alveoli from the capillaries, the lung has developed a highly efficient and balanced immune system which maintains balance between inflammation and tolerance. Studies on the role of the innate immune system in protecting against inhalational anthrax have focused mainly on alveolar phagocytes such as macrophages and dendritic cells. Anthrax is a disease caused by Bacillus anthracis, a Gram-positive, rod-shaped, spore-forming bacterium whose spores are considered a serious bioterrorism agent (25) . B. anthracis spores cause three main clinical forms of the disease, depending on the route of infection: cutaneous, inhalational, and gastrointestinal anthrax (16) . Intriguingly, prognoses of B. anthracis mucosal infections (pulmonary and intestinal) are dreadful, whereas cutaneous infection is known to be diagnosed easily and is readily cured. This suggests that the mucosal and skin-associated immune systems differ greatly in their handling of the pathogen.
The pulmonary route of infection is of paramount interest in terms of bioterrorism. The pathophysiology of inhalational anthrax is still a matter of discussion (7, 16, 47) . It has been studied in multiple models, including mainly mouse, guinea pig, rabbit, and nonhuman primate (NHP) models, among which rodents are by far the most studied species (16, 50) . In mice, recent studies have proven that entry of B. anthracis is not restricted to the lower respiratory tract, as initially thought, but may occur dually at the upper airways through the nasal mucosa-associated lymphoid tissue (NALT) (14, 15) . In the lower respiratory tract, we and others have already shown that B. anthracis spores are managed during early infection in a coordinated manner by lung phagocytes (46, 49) . Spores are immediately phagocytosed by alveolar macrophages lodged along the alveolar pneumocytes. Lung epithelial cells have also been described to phagocytose spores after inhalation (43) . After a slight delay, lung dendritic cells (DCs) capture spores and rapidly transport them to the draining thoracic lymph nodes, playing the role of a Trojan horse (5) . There, the spores start to transform into metabolically active, toxin-producing, replicating bacilli. B. anthracis toxins are formed by the association of enzymatically active moieties, lethal factor (LF) and edema factor (EF), with protective antigen (PA) as a cell surface binding component, generating lethal toxin (LT) and edema toxin (ET), respectively (36) . Both toxins play a major role in bacterial evasion of the host innate and adaptive immune systems (47, 48) .
So far, little is known about the lung innate immune responses that are triggered after spore phagocytosis and processing. The specific role of neutrophils in lung immunity has not been explored thoroughly, although one report suggests it to be minor (6) . Indirect arguments based on subcutaneous and intravenous models of infection were recently reported. Using myeloidspecific B. anthracis toxin receptor capillary morphogenesis protein 2 (CMG2) knockout mice, it was shown that toxin impairment of myeloid cells, including neutrophils, is critical for establishing disease (31) .
Interleukin-17 (IL-17) is the prototype of a large family of six cytokines that play a potent role in regulating neutrophil responses (10, 51) . IL-17 (also referred as IL-17A) in association with IL-17F-both of which are capable of signaling through IL-17 receptor A (IL-17RA)-acts as a master coordinator of the response. Neutrophil recruitment is induced indirectly by IL-17 through triggering of epithelial cells to secrete CXC chemokines (27) . The protective role of IL-17 in host defense against pathogens in the lung has been demonstrated for numerous pathogens, including bacteria, fungi, and viruses (reviewed in reference 26). IL-17 can be either protective or detrimental, as recently exemplified in cases of influenza virus infection, as IL-17RA knockout mice survived significantly longer than wild-type (WT) mice (9) . This highlights the delicate balance between inflammation and clearance of infection in the lung, as well as the role played by neutrophils and IL-17.
Several studies have pointed out the variety of IL-17 sources at mucosal sites, emphasizing that IL-17 bridges innate and adaptive immunity (10) . In the lung, besides the classical Th17 lineage, innate cells such as ␥␦ T and NKT cells produce IL-17 during infection, sparking a quick start to the immune response. Recent reports suggest that neutrophils may also be a novel player in the game, as shown in noninfectious inflammation models such as acute ischemia-reperfusion in the kidney (30) , lung lipopolysaccharide (LPS)-induced neutrophilia (13) , and acute vasculitis (23) . More recently, neutrophils have been shown to produce IL-17A in the lung after fungal infection by Cryptococcus neoformans (55) and Aspergillus fumigatus (54) . Taken together, the extended diversity of IL-17 sources in response to stress or pathogens emphasizes its roles from early to late stages of infection. Given the critical roles of IL-17A and -F in lung immunity and elimination of extracellular pathogens (26), we hypothesized that these cytokines would be induced by B. anthracis infection in the lung mucosal immune system.
In the present study, we identified neutrophils as the main cell population secreting IL-17 in a pulmonary model of B. anthracis infection. Using IL-17RA Ϫ/Ϫ mice, we showed that the IL-17A/F axis is instrumental for recruiting neutrophils to the lung. We also showed that the IL-17A/F axis is critical for survival of pulmonary B. anthracis infection, as IL-17RA Ϫ/Ϫ mice became susceptible to intranasal (i.n.) infection with Sterne spores. Eventually, by depleting neutrophils in wild-type and IL-17RA Ϫ/Ϫ mice, we demonstrated the crucial role of IL-17-secreting neutrophils in mouse survival after infection with a fully virulent capsulated strain. This work demonstrates the very important roles of both IL-17 and neutrophils in the clearance of this lung pathogen and in surviving pulmonary anthrax.
MATERIALS AND METHODS
Animals. Six-to 10-week-old A/J mice (Harlan), C57BL/6 WT mice (CERJ), IL-17RA Ϫ/Ϫ mice (obtained from Bernhard Ryffel, CNRS UMR6218, Orléans, France), and CX 3 CR1 ϩ/gfp mice (Jackson Laboratories) were housed under clean standard conditions. IL-17RA Ϫ/Ϫ and CX 3 CR1 ϩ/gfp mice (all on a C57BL/6 background) were bred at the Plateforme de Haute Technologie Animale (La Tronche, France). All experimental protocols were approved by the local animal use committee according to international guidelines.
Bacillus anthracis strains. B. anthracis Sterne 7702 (pXO1 ϩ pXO2 Ϫ ) and the fully virulent strain 17JB (pXO1 ϩ pXO2 ϩ ) were provided by Michèle Mock (Institut Pasteur, Paris, France).
Preparation of spores. Stocks of B. anthracis strains were prepared as follows. Bacteria were streaked on nutrient broth-yeast extract (NBY) agar slants and incubated for 7 days at 30°C. Five milliliters of sterile distilled water was added to each slant, and the samples were suspended. The spore suspension was incubated in a sterile screw-cap tube at 65°C in a water bath for 30 min to kill any remaining bacilli. The spores were collected by centrifugation and resuspended in water (1/20 [vol/vol] of the original culture) to give samples containing at least 90% spores and 10 8 CFU/ml. Spores were purified by differential centrifugation for 30 min at 6,000 ϫ g at ϩ4°C through layers of 45 to 55% Radioselectan (Renografin 76%; Schering) prepared in distilled water. Free spores contained in the pellet were washed three times with water to remove residual Renografin and then stored in deionized water. All spore stocks were stored at Ϫ80°C until use. Prior to each infection of mice, aliquots were diluted and viable spore counts estimated.
Immunization and infection of mice. Mice were immunized by subcutaneous (s.c.) injection with 10 g of recombinant PA (List Biological Laboratories Inc.) and 0.3% aluminum hydroxide gel (Sigma-Aldrich) in 100 l of vaccine 20 days before infection, with a booster given 10 days before infection.
For i.n. challenge, mice were lightly anesthetized with O 2 -isoflurane (2.5%), and 25 l of a spore solution diluted in phosphate-buffered saline (PBS) at various concentrations was instilled in each nostril. Animal infections were performed in biosafety level 2 (BSL2) and BSL3 facilities, depending on the strain type.
Bacterial counting. For bacterial enumeration, mice were infected intranasally with 2 ϫ 10 8 spores of Sterne strain 7702 and killed at 3 days postinfection. Suspensions of lung cells were obtained by mechanical disruption in 1 ml of ice-cold distilled water. Homogenates were then serially diluted (for bacillus counting) or heated at 65°C for 30 min prior to dilutions for spore counting. Thereafter, we added 18 ml of Trypticase soy agar medium (Becton Dickinson) (cooled to ϳ45°C). Sample dilutions and agar medium were thoroughly mixed by alternating rotation and back-and-forth motion of plates. We let the agar solidify and incubated it promptly for 24 h at 37°C prior to CFU counting.
Neutrophil depletion. Use of a Ly6G-specific monoclonal antibody is an established technique for depleting neutrophils in mice in vivo (11, 38) . In our study, mice were injected intraperitoneally (i.p.) with 100 l of 1A8 monoclonal antibody (BioXCell) at a concentration of 0.25 mg/ml in PBS. Five hours following neutrophil depletion, mice were infected by the intranasal route with 2 ϫ 10 8 spores of Sterne strain 7702, and survival was monitored each day until day 15. Injection was repeated on days 1 and 2 and then every 2 days until day 15, the last time point of the survival experiments.
Complement depletion. C57BL/6 mice were injected i.p. with two 5-U doses of cobra venom factor (CVF) 4 h apart to deplete the animals of C5 (19, 44) . The mice were injected with 5 U of CVF every fifth day until day 15.
Forty-eight hours following CVF injection, mice were infected by the intranasal route with 2 ϫ 10 8 spores of Sterne strain 7702, and survival was monitored each day until day 15.
BAL and lung cell analysis. For bronchoalveolar lavage (BAL), 1 ml of ice-cold PBS-2 mM EDTA (Sigma-Aldrich) was injected into the trachea, collected, and kept on ice prior to treatment. Single-cell suspensions of lung cells were obtained after physical dissociation using a GentleMACS dissociator (Miltenyi Biotec) followed by enzymatic digestion (30 min in a humidified incubator at 37°C with 5% ambient CO 2 ) of lung tissue in RPMI 1640 medium (Sigma-Aldrich) containing collagenase type I (1 mg/ml; Worthington Biochemical) and DNase I (50 U/ml; Sigma-Aldrich). Red blood cells were lysed in NH 4 Cl (1ϫ) solution. Cells were resuspended in PBS-1% bovine serum albumin (BSA)-0.1% azide before staining.
For microscopy analysis, lung preparations were cytocentrifuged and mounted with Vectashield DAPI medium (4=,6-diamidino-2-phenylindole; Dako) or stained with Giemsa stain (RAL 555 kit). Cells were examined on a Zeiss Axioplan 2 microscope to image Giemsa staining and on an Olympus IX-81 microscope for fluorescence microscopy.
Flow cytometry analysis. Lung cell suspensions were incubated with Fc receptor blocking antibody (anti-mouse CD16/CD32 Ab, clone 2.4G2; BD Biosciences) for 30 min at 4°C. We used the following monoclonal antibodies (MAbs) (all from BD Biosciences, except where stated otherwise): anti-mouse CD3 (145-2C11), CD4 (L3T4), CD8␣ (53-6.7), CD11b (M1/70), CD11c (H3L), CD25 (3C7), CD45 (30-F11), CD335 (NKp46, 29A1.4), Gr-1 (RB6-8C5), T-cell receptor ␥␦ (TCR␥␦) (GL3), Ly6G (1A8), TCR␤ (H57-597; eBiosciences), and CD1d tetramer (a kind gift of Murielle Pichavant, Institut Pasteur de Lille), as well as correspond-ing isotypes. Cells were stained for 30 min at 4°C. For intracellular staining, cells were permeabilized with saponin and stained for 1 h at 4°C with IL-17A MAb (eBio17B7; eBiosciences). Cell acquisition was conducted on a model FC500 (Beckman Coulter) flow cytometer, and data were analyzed with FlowJo software.
Cytokine measurement. Cytokine concentrations in BAL fluid (BALF) were measured by enzyme-linked immunosorbent assay (ELISA), using a DuoSet assay for IL-17A and IL-17F and a Quantikine immunoassay (R&D Systems) for IL-22, IL-6, IL-12p70, and gamma interferon (IFN-␥), according to the manufacturer's instructions.
Statistical analysis. Statistical analysis was performed using GraphPad Prism software (version 4.0c; GraphPad Software, Inc.). Statistical differences between the groups were determined by a nonparametric test, the Mann-Whitney test, and by the log rank test for survival analysis.
RESULTS
IL-17A and IL-17F are present in BALF after inhalational anthrax. We first aimed to determine whether IL-17 is produced after i.n. infection with B. anthracis. We therefore investigated the cytokines present in the BALFs of A/J mice (C5 deficient), a largely used model of mouse infection with strain Sterne (Fig. 1A) . Mice were infected with B. anthracis Sterne strain 7702 via the i.n. route and were sacrificed serially from day 0 (noninfected) to day 4 to determine the cytokine concentrations in the BALF samples.
We observed a robust production of IL-17A, IL-22, IL-6, IL12p70, and IFN-␥ in the BALF samples starting as soon as 24 h postinfection and reaching a peak at day 3 (Fig. 1A) . Beyond this time point, mice started to die, and all mice were dead by day 4. Since IL-17A, IL-17F, and IL-22 were produced in significant amounts on day 3, we focused the rest of our investigations on this time point (Fig. 1B) . Using different doses of B. anthracis spores, we observed that IL-17A was produced significantly only with an infective quantum above 2 ϫ 10 8 spores per mouse (Fig. 1C) . Furthermore, for A/J mice as well as C57BL/6 and IL-17RA Ϫ/Ϫ mice (used later in this study), CFU analysis did not show any germination in the lungs following infection ( Fig. 2A and B) .
These initial results showed that infection with B. anthracis spores leads to local IL-17A, IL-17F, and IL-22 production.
IL-17A is produced by neutrophils recruited to the lungs of A/J mice. Next, we investigated the cell population secreting IL-17A in A/J mouse lungs. In accordance with our aforementioned data, an IL-17A ϩ cell population was recruited to mouse lungs after infection and represented up to 11.4% of the total cells (Fig.  3A) . This population was around 1% in noninfected mice. Moreover, the mean fluorescence intensity (MFI) of IL-17 ϩ cells was significantly higher for the infected than the noninfected group (Fig. 3B) . We extensively analyzed the IL-17A ϩ cell population phenotype (Fig. 3C ). In agreement with our initial results, no more than about 6% of the IL-17A ϩ population was mature T cells (CD3 ϩ TCR␣␤ ϩ ), demonstrating that most of the recruited cell population did not belong to the classical Th17 lineage. We also excluded CD8 ϩ , Treg (CD3 ϩ CD25 ϩ ), and CD4 ϩ cell populations. We then focused on ␥␦ T cells, NKT (TCR␣␤ ϩ CD1d tetramer ϩ ) cells, and NK (NKp46 ϩ CD3 ϩ ) cells, which play a role in innate IL-17 production in the mucosa (10) . None of these innate cell populations produced IL-17. Finally, we found that most IL-17A ϩ cells (ϳ90%) in the lungs of infected A/J mice were neutrophils (CD11b ϩ Gr-1 high Ly6G ϩ ). Furthermore, we observed that IL-17 ϩ cell MFIs were significantly higher for neutrophils than for Th17 populations (Fig. 3D) , confirming that neutrophils are the main producer of IL-17.
IL-17A is produced mainly by CD11b ؉ Gr-1 high CX 3 CR1 ؊ neutrophils recruited to the lungs of C57BL/6 mice. In parallel, we performed the same analysis on C57BL/6 mouse lungs (Fig.  4A) , because A/J mice are deficient in C5 and this factor is critical for IL-17 production by T cells (20) . Using knock-in heterozygous CX 3 CR1 ϩ/gfp mice, we could differentiate monocytes (CX3CR1 ϩ ) and neutrophils (CX3CR1 Ϫ ) that both express Gr-1 (29). We confirmed that the IL-17 ϩ population corresponded to CD11b ϩ Gr-1 high CX 3 CR1 Ϫ cells (Fig. 4B) . Accordingly, IL-17A-positive cells exhibited multilobulated ring-shaped nuclei characteristic of neutrophils (Fig. 4C) .
The neutrophil population was recruited to the lung upon infection in A/J and C57BL/6 mice (Fig. 5A) . Interestingly, IL-17 ϩ cells represented a significant subset of about 40% in A/J mice and 30% in C57BL/6 mice among the total neutrophils (Fig. 5B) .
To determine a putative role of Th17 cells in resolving infection in A/J mice, we performed experiments on PA-immunized mice allowing mature T cell differentiation. In contrast to the case for naïve animals, IL-17A and IL-17F levels in BALFs of vaccinated mice were not different from those for noninfected animals at day 3 postinfection (Fig. 6A) . Even 15 days following infection, we did not observe any IL-17 production in immunized mice (data not shown). Since C57BL/6 mice survive Sterne strain infection, we analyzed IL-17-producing cells in lungs for up to 6 days after infection to rule out the role of Th17 cells. At day 6, we found no significant increase of the Th17 ϩ cell phenotype compared to that in uninfected animals (Fig. 6B) . Taken together, these results show that mature T cells did not participate in IL-17 production in the A/J and C57BL/6 models of inhalational anthrax by a Sterne strain.
Impaired recruitment of neutrophils in IL-17RA ؊/؊ mice leads to susceptibility to intranasal Sterne strain infection but not to infection with a fully virulent strain. We next examined the role of IL-17A/F axis signaling during recruitment of the neutrophil population by using IL-17RA Ϫ/Ϫ mice. Although we did not observe a decrease of the IL-17A ϩ cell percentage in the lungs of IL-17RA Ϫ/Ϫ mice compared with WT animals when we gated on total cells, it was significantly diminished when the gating strategy was restricted to the neutrophils (Fig. 7A) . One can infer that in the absence of an IL-17A/F retrofit, some other cell populations compensate for the lower recruitment of IL-17-secreting neutro- phils. We observed an increased percentage of CD11b ϩ Gr-1 int cells, which may be monocytes (Fig. 7A) .
In contrast, neutrophil recruitment was significantly impaired in IL-17RA Ϫ/Ϫ mice compared with that in WT animals (Fig. 7B) . We also observed a lower level of neutrophils in IL-17RA Ϫ/Ϫ naïve mice compared to WT noninfected mice, in accordance with a previous study (57) and other literature suggesting a role of IL-17 during granulopoiesis and migration of neutrophils in tissues (3, 33) .
Next, we investigated the effects of IL-17A/F signaling knockout on mouse survival by using the acapsulated Sterne and fully virulent 17JB strains. IL-17RA Ϫ/Ϫ mouse survival was impaired significantly compared with that of WT mice, which are resistant to i.n. B. anthracis Sterne infection (52) . This result highlights the critical role played by the IL-17 axis against B. anthracis at the lung mucosa in an acapsulated strain infection model (Fig. 7C) . In sharp contrast, we did not observe any differences when we used a capsulated fully virulent strain, suggesting that protection against a capsulated strain does not depend on the IL-17 axis (Fig. 7D) .
Neutrophils are critical for resolution of infection by a fully virulent capsulated strain of B. anthracis. Finally, we sought to assess the role of neutrophils recruited to the lung in protection against Sterne strain and fully virulent models of infection. In the C5-deficient A/J mouse model depleted of neutrophils (Fig. 8A and B) and infected with the Sterne strain, we observed only a slight significant decrease in time to death among depleted mice (Fig. 8C) . We then determined the effects of neutrophil depletion in complement-sufficient WT and IL-17RA Ϫ/Ϫ mice (Fig. 8D) . After infection by the Sterne strain, we observed only a slight, nonsignificant difference between the depleted and nondepleted groups (Fig. 8E) . These results suggested that protection against an acapsulated strain depends strongly on the IL-17 axis but only partially upon neutrophil recruitment. Since we observed an increase of time to death only for A/J C5-deficient mice compared to the survival among C5-sufficient C57BL/6 mice, we tried to address the role of C5 in survival. To that end, we assessed the survival of C57BL/6 mice after depletion of C5 by CVF. We did not observe any differences between WT and C5-depleted mice (data not shown), suggesting that C5 deficiency did not account for the differences between the A/J and C57BL/6 backgrounds. We eventually infected depleted and nondepleted WT mice with the fully virulent capsulated 17JB strain and observed a significant decrease in survival time, thereby demonstrating that neutrophils play a critical role in protection against lung B. anthracis infection (Fig. 8F ).
DISCUSSION
Our study identified IL-17 as one of the first innate immune alarms after B. anthracis infection of the lungs and determined that neutrophils are the primary source of IL-17. We also demonstrated that IL-17 ϩ neutrophils are recruited upon infection and that the IL-17 axis is necessary for amplifying its own recruitment. To our knowledge, this is one of the first reports that IL-17-secreting neutrophils are a central producer of IL-17 in an infected mucosa, playing a critical role in survival.
Neutrophils are a vital component of the acute cellular inflammatory system and defense against intruding microorganisms (3, 37) . At homeostasis, neutrophils are recruited through their CXCR4 chemokine receptor for rapid clearance of bacteria. However, they can cause lung injury when their recruitment is dysregulated (28) . IL-17 is instrumental in lung neutrophil recruitment via its effect on epithelial cells, which in turn produce granulopoietic factors such as granulocyte colony-stimulating factor (G-CSF) and CCL20 (10) . The role of IL-17 in neutrophil recruitment has been demonstrated largely with large panels of extracellular Each symbol represents one mouse. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; ns, not significant. pathogens, mainly as an early requirement, within 4 to 8 h after exposure (10). In our model, IL-17 was detected from day 2 onwards, and its level increased until death. Interestingly, the mean time to death was 8 to 9 days for IL-17RA Ϫ/Ϫ mice, which is much later than that for acute infection with a susceptible strain. This suggests that neutrophil-related IL-17 sustains the recruitment of new neutrophils to the infected site at the later stages of infection. Although neutrophil-related IL-17 is classified as an innate response, its role is delayed until the late phase of lung scavenging. IL-17 is known to induce CXC chemokines (57), some of which possess antimicrobial properties against B. anthracis spores and bacilli (8) . This could be another IL-17 effector mechanism of action, independent of neutrophils. Here we demonstrated that lung neutrophils produce IL-17. A previous study with a model of lung neutrophilia induced by LPS instillation reported the detection of IL-17 mRNA in neutrophils (13) . Subsequently, it was shown that IL-17 can be produced by non-T cells during "sterile" inflammation of the kidneys (30) and in a model of acute vasculitis (23) . Intriguingly, in a model of Helicobacter hepaticus-induced colitis, Gr-1 ϩ CD11b ϩ cells produced a significant amount of IL-17 in the gut lamina propria (24) . More recent data favor a role of neutrophils in IL-17A production in the lung after fungal infection by C. neoformans (55) or A. fumigatus (54) . Our study provides a new, nonfungal pathogen on the list of neutrophil IL-17 inducers. According to our data, IL-17 is produced by a subset of neutrophils which represent about 30 to 40% of the total CD11b ϩ Gr-1 high cell population in the infected lungs. This subpopulation is crucial for sustained recruitment of neutrophils during infection with an acapsulated strain, as illustrated with IL-17RA knockout mice. Neutrophil-related IL-17 induces a stimulating loop of recruitment for inflammatory effectors such as neutrophils and monocytes. It should be noted that production of IL-17 in A/J mice infected with an acapsulated strain depends on the level of infection. This could mean that below a certain quantum, neutrophils are not activated to produce IL-17. Interestingly, the role of the IL-17 axis might differ during infections by acapsulated versus capsulated B. anthracis, as shown by mouse survival. This is not surprising given that mice are sensitive to capsulated B. anthracis devoid of toxins (21, 53) , demonstrating the unique role of capsule in virulence (12) . This may suggest that IL-17 axis-dependent effectors are ineffective against capsulated strains. Conversely, major capsule effects upon infection dissemination may mask subtle differences observed with the Sterne strain in mice. Interestingly, the capsulated virulent strain 17JB did not trigger a detectable level of IL-17 in BALF (data not shown). Since the capsule allows dissemination to distal organs (12) , it could mean that the pathogen spreads before a certain level of activation is reached in the lung. In our study, we focused on the lung, although IL-17 could participate in controlling infection at alternate sites, such as the NALT or the lymph nodes. Alternatively, the infective dose The role of neutrophils in anthrax disease was first recognized by the seminal work of Elie Metchnikoff on phagocytosis in the late 19th century (34) . Over time, the role of neutrophils in pul- monary anthrax has been masked progressively by studies focusing on the first cell responder that is directly on-site: the alveolar macrophages (6) . Human neutrophils can kill spores and fully virulent capsulated bacilli (32) , suggesting that they scavenge infected tissues. It has been known for a long time that B. anthracis toxins dampen the recruitment (39) and priming (56) of neutrophils. LT impairs production of IL-8, which is a critical chemokine for neutrophil recruitment, acting on epithelial (40) and endothe- lial (2) cells through at least two molecular mechanisms. The role of neutrophils in anthrax was recently brought back into the limelight in a study using myeloid lineage CMG2-deficient mice (31) . According to this study, toxin receptor inactivation renders mice resistant to s.c. or intravenous (i.v.) models of B. anthracis infection. The toxin effects were mediated mainly by neutrophil impairment. In another study, mice bearing Nlrp1b-sensitive alleles for macrophage lysis were resistant to infection, through caspase 1 activation, IL-1␤ signaling, and neutrophil recruitment following s.c. challenge (35) .
Beyond our mouse models, one interesting question is the relevance of such findings to neutrophils in other animal models and, ultimately, humans. The main documents on humans are from necropsy analyses of the Sverdlosk incident in 1979 and the U.S. outbreak in 2001. In the Sverdlosk accident cohort, a neutrophilic infiltration was noticed for 37% of microscopic lung analyses (17) . In contrast, during the 2001 outbreak, various degrees of monocytic infiltration were noticed on lung necropsy of deceased patients (18) . Both studies report major inflammatory lesions with alveolar edema and hyaline membrane formation. Since these reports are based on terminal state examination, they may be biased toward patients whose immune systems did not handle the pathogen properly and thus may miss neutrophil involvement. Research of the most relevant animal model of inhalational anthrax has been compared to a quest for the Holy Grail (16) . NHPs have been used widely over the past 60 years (50) . Interestingly, neutrophilic infiltration has been reported in most studies using more distant species (1, 45) . Neutrophils were found to various degrees on lung tissue necropsy of rabbits (50) , as well as in historical studies of guinea pigs (41, 42, 50) . Taken together, these data indicate that neutrophils are recruited into the lung in most animal models of B. anthracis infection. The role of neutrophils has largely been undetermined so far, mainly because their recruitment is faint compared to that in other major lung histological disorders.
Our data confirm the critical role of the IL-17 axis in survival with an acapsulated-toxigenic Sterne strain and of neutrophils in survival with a fully virulent strain in a mouse model of pulmonary anthrax. These data draw a more complicated picture of the host innate immune response to B. anthracis infection, including the roles of IL-17 and neutrophils in clearing of the lungs.
